Elevated Aβ aggregates in feces from Alzheimer's disease patients: a proof-of-concept study

被引：1

作者：

Pils, Marlene ^{[1
,2
]}

Dybala, Alexandra ^{[3
]}

Schaffrath, Anja ^{[1
]}

Rehn, Fabian ^{[1
,2
]}

Kutzsche, Janine ^{[1
]}

Bloemeke, Lara ^{[1
]}

Tusche, Markus ^{[1
]}

Oezduezenciler, Pelin ^{[1
]}

Bujnicki, Tuyen ^{[1
]}

Kraemer-Schulien, Victoria ^{[1
]}

Gramespacher, Hannes ^{[4
]}

Schmieschek, Maximilian H. T. ^{[4
]}

Barbe, Michael T. ^{[4
]}

Onur, Oezguer A. ^{[4
,5
]}

Fink, Gereon R. ^{[4
,5
]}

Tamguney, Gultekin ^{[1
,3
]}

Bannach, Oliver ^{[1
,2
]}

Willbold, Dieter ^{[1
,2
,3
]}

机构：

[1] Forschungszentrum Julich, Inst Biol Informat Proc, Struct Biochem IBI 7, D-52428 Julich, Germany

[2] attyloid GmbH, D-40225 Dusseldorf, Germany

[3] Heinrich Heine Univ Dusseldorf, Inst Phys Biol, D-40225 Dusseldorf, Germany

[4] Univ Cologne, Univ Hosp Cologne, Fac Med, Dept Neurol, D-50937 Cologne, Germany

[5] Res Ctr Julich, Inst Neurosci & Med INM 3, Cognit Neurosci, D-52428 Julich, Germany

来源：

ALZHEIMERS RESEARCH & THERAPY | 2024年 / 16卷 / 01期

关键词：

Amyloidosis; A beta oligomer quantitation; sFIDA; Brain-gut-microbiota axis; Leaky gut; Fecal/stool samples; Clearance; MILD COGNITIVE IMPAIRMENT; CEREBROSPINAL-FLUID; GUT-MICROBIOTA; DIAGNOSIS; BRAIN;

D O I：

10.1186/s13195-024-01597-3

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

BackgroundMisfolding and aggregation of amyloid beta (A beta), along with neurofibrillary tangles consisting of aggregated Tau species, are pathological hallmarks of Alzheimer's disease (AD) onset and progression. In this study, we hypothesized the clearance of A beta aggregates from the brain and body into the gut.MethodsTo investigate this, we used surface-based fluorescence intensity distribution analysis (sFIDA) to determine the A beta aggregate concentrations in feces from 26 AD patients and 31 healthy controls (HC).ResultsA beta aggregates were detectable in human feces and their concentrations were elevated in AD patients compared to HC (specificity 90.3%, sensitivity 53.8%).ConclusionThus, fecal A beta aggregates constitute a non-invasive biomarker candidate for diagnosing AD. Whether digestion-resistant A beta aggregates in feces are secreted via the liver and bile or directly from the enteric neuronal system remains to be elucidated.

引用

页数：15

共 50 条

[31] Gut Microbiota is Altered in Patients with Alzheimer's Disease
Zhuang, Zhen-Qian
Shen, Lin-Lin
Li, Wei-Wei
Fu, Xue
Zeng, Fan
Gui, Li
Lu, Yang
Cai, Min
Zhu, Chi
Tan, Yin-Ling
Zheng, Peng
Li, Hui-Yun
Zhu, Jie
Zhou, Hua-Dong
Bu, Xian-Le
Wang, Yan-Jiang
JOURNAL OF ALZHEIMERS DISEASE, 2018, 63 (04) : 1337 - 1346
[32] Transplantation of feces from mice with Alzheimer's disease promoted lung cancer growth
Bi, Wangyu
Cai, Shanglin
Hang, Zhongci
Lei, Tong
Wang, Donghui
Wang, Li
Du, Hongwu
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2022, 600 : 67 - 74
[33] Elevated Glutamate and Glutamine Levels in the Cerebrospinal Fluid of Patients With Probable Alzheimer's Disease and Depression
Madeira, Caroline
Vargas-Lopes, Charles
Brandao, Carlos Otavio
Reis, Taylor
Laks, Jerson
Panizzutti, Rogerio
Ferreira, Sergio T.
FRONTIERS IN PSYCHIATRY, 2018, 9
[34] Use of risedronate to prevent bone loss following a single course of glucocorticoids: findings from a proof-of-concept study in inflammatory bowel disease
Kriel, M. H.
Tobias, J. H.
Creed, T. J.
Lockett, M.
Linehan, J.
Bell, A.
Przemioslo, R.
Smithson, J. E.
Brooklyn, T. N.
Fraser, W. D.
Probert, C. S. J.
OSTEOPOROSIS INTERNATIONAL, 2010, 21 (03) : 507 - 513
[35] Magnetic Resonance Imaging for Monitoring of Hepatic Disease Induced by Ebola Virus: a Nonhuman Primate Proof-of-Concept Study
Lee, Ji Hyun
Calcagno, Claudia
Feuerstein, Irwin M.
Solomon, Jeffrey
Mani, Venkatesh
Huzella, Louis
Castro, Marcelo A.
Laux, Joseph
Reeder, Rebecca J.
Kim, Dong-Yun
Worwa, Gabriella
Thomasson, David
Hagen, Katie R.
Ragland, Danny R.
Kuhn, Jens H.
Johnson, Reed F.
MICROBIOLOGY SPECTRUM, 2023, 11 (03)
[36] A randomized, double-blind, phase 2b proof-of-concept clinical trial in early Alzheimer's disease with lecanemab, an anti-Aβ protofibril antibody
Swanson, Chad J.
Zhang, Yong
Dhadda, Shobha
Wang, Jinping
Kaplow, June
Lai, Robert Y. K.
Lannfelt, Lars
Bradley, Heather
Rabe, Martin
Koyama, Akihiko
Reyderman, Larisa
Berry, Donald A.
Berry, Scott
Gordon, Robert
Kramer, Lynn D.
Cummings, Jeffrey L.
ALZHEIMERS RESEARCH & THERAPY, 2021, 13 (01)
[37] The Alzheimer's Questionnaire: A Proof of Concept Study for a New Informant-Based Dementia Assessment
Sabbagh, Marwan N.
Malek-Ahmadi, Michael
Kataria, Rahul
Belden, Christine M.
Connor, Donald J.
Pearson, Caleb
Jacobson, Sandra
Davis, Kathryn
Yaari, Roy
Singh, Upinder
JOURNAL OF ALZHEIMERS DISEASE, 2010, 22 (03) : 1015 - 1021
[38] Reversed Mirror Therapy (REMIT) after Stroke-A Proof-of-Concept Study
Tesio, Luigi
Caronni, Antonio
Russo, Cristina
Felisari, Giorgio
Banco, Elisabetta
Simone, Anna
Scarano, Stefano
Bolognini, Nadia
BRAIN SCIENCES, 2023, 13 (06)
[39] Towards Chronic Liver Dysfunction Self-monitoring: a Proof-of-Concept Study
Germanese, Danila
Colantonio, Sara
D'Acunto, Mario
Brunetto, Maurizia
Romagnoli, Veronica
Salvati, Antonio
2019 IEEE SYMPOSIUM ON COMPUTERS AND COMMUNICATIONS (ISCC), 2019, : 1107 - 1112
[40] Noninvasive Differentiation between Hepatic Steatosis and Steatohepatitis with MR Imaging Enhanced with USPIOs in Patients with Nonalcoholic Fatty Liver Disease: A Proof-of-Concept Study
Smits, Loek P.
Coolen, Bram F.
Panno, Maria D.
Runge, Jurgen H.
Nijhof, Wouter H.
Verheij, Joanne
Nieuwdorp, Max
Stoker, Jaap
Beuers, Ulrich H.
Nederveen, Aart J.
Stroes, Erik S.
RADIOLOGY, 2016, 278 (03) : 782 - 791

← 1 2 3 4 5 →